Almuhareb Alanoud, Al Sharif Abdullah, Cahusac Peter
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Front Glob Womens Health. 2024 Jul 24;5:1402608. doi: 10.3389/fgwh.2024.1402608. eCollection 2024.
Medication use during pregnancy is limited by the scarcity of safety data for many drugs. The use of certain drugs during pregnancy can be teratogenic. Overestimating teratogenic medication risk could have serious consequences from drug non-adherence. Assessing and understanding the knowledge, attitude, and practice of medication use among pregnant women is crucial to optimizing the health of pregnant women and their fetuses.
An observational cross-sectional study used convenience and snowball sampling with a self-administered online questionnaire in 562 pregnant women from Riyadh City. The questionnaire used was adapted from previously published surveys. The survey included sections on sociodemographic background, awareness of medication risks, medication use during pregnancy, sources of drug information, and statements from the Beliefs about Medicines Questionnaire (BMQ), both general and pregnancy-specific.
Medication use during pregnancy was reported by 44.7%. The primary source for medication information for the majority was the physician. Over 58% indicated inadequate or inconsistent information about medication from physicians. Additionally, 65.7% confirmed not receiving sufficient or inconsistent information from pharmacists during medication dispensing. The responses to the questionnaire reveal a commendable level of knowledge and positive attitude and practice. However, variations could be found in these responses. Overall, no evident relationships were observed between predictors and responses, except in specific statements that indicated a positive association between beliefs and higher levels of education and youth.
The results suggest a positive knowledge, attitude, and practice level. However, there was hesitancy and a restrictive attitude towards medication during pregnancy. The study identified inadequate education provided by healthcare professionals, thus presenting an area for improvement to enhance the safety and efficacy of medication use during pregnancy.
由于许多药物的安全性数据匮乏，孕期用药受到限制。孕期使用某些药物可能具有致畸性。高估致畸药物风险可能因不坚持用药而产生严重后果。评估和了解孕妇用药的知识、态度和行为对于优化孕妇及其胎儿的健康至关重要。
一项观察性横断面研究采用便利抽样和雪球抽样方法，对利雅得市562名孕妇进行了在线自填问卷调查。所使用的问卷改编自先前发表的调查。该调查包括社会人口学背景、药物风险意识、孕期用药情况、药物信息来源以及《药物信念问卷》（BMQ）中的一般性和孕期特定性陈述等部分。
44.7%的孕妇报告在孕期使用过药物。大多数人获取药物信息的主要来源是医生。超过58%的人表示从医生那里获得的药物信息不足或不一致。此外，65.7%的人证实，在配药过程中未从药剂师那里获得足够或一致的信息。问卷回复显示出值得称赞的知识水平、积极态度和行为。然而，这些回复中存在差异。总体而言，除了某些特定陈述表明信念与较高教育水平和年轻之间存在正相关外，未观察到预测因素与回复之间存在明显关系。
结果表明知识、态度和行为水平良好。然而，孕妇对孕期用药存在犹豫和限制态度。该研究发现医疗保健专业人员提供的教育不足，因此提出了一个需要改进的领域，以提高孕期用药的安全性和有效性。
